Lampard Inquiry May Issue Early Safety Recommendations on Essex Mental Health Deaths

The public inquiry led by Baroness Kate Lampard into mental health deaths in Essex has indicated it may release interim findings within weeks if urgent patient safety risks are identified. The investigation is examining the circumstances surrounding more than 2,000 fatalities that occurred between 2000 and the end of 2023 among individuals receiving care from Essex mental health services.

Baroness Lampard confirmed that further evidence will be heard during hearings commencing on 5 October. Following these sessions, the inquiry will determine whether immediate recommendations are necessary ahead of a final report, which is not expected until 2028. Any early recommendations are anticipated to address inpatient safety concerns, specifically focusing on resuscitation protocols and the monitoring technologies used to detect patients in distress.

Emphasizing the broader significance of the inquiry, Lampard stated that the findings would be of “national interest” and relevant to service providers across England. “Those two matters are not specific to Essex,” she noted, adding that the evidence could have implications for care and treatment provided on all mental health units nationwide.

A central point of examination is Oxevision, an infrared camera system placed in bedrooms to monitor patients’ breathing and pulse rates without physical contact. The technology, operated by LIO Health, is utilized by several NHS mental health trusts in England. While the company asserts that Oxevision helps prevent serious incidents, supports staff, and reduces administrative paperwork, relatives of deceased patients have raised significant concerns.

Critics argue that the system compromises patient dignity and privacy, potentially replacing essential face-to-face interaction. Tammy Smith, whose daughter Sophie Alderman died in 2022, told the inquiry that the technology removes human connection. “They need those conversations. They need someone to ask, ‘Are you OK? Do you need anything?’ We all need that,” Smith said, highlighting the vulnerability of patients who require direct human contact.

NHS England has stated that any vision-based monitoring must adhere to a human rights-based approach to care, comply with legal requirements, and be used with appropriate patient consent. The upcoming hearings, held at Chelmsford Civic Centre rather than the previous London venue, will include testimony from NHS England, the Care Quality Commission, and the Medicines and Healthcare products Regulatory Agency between 5 and 15 October.

Families are scheduled to provide their views on potential recommendations during a virtual hearing on 20 October, after which Baroness Lampard will decide whether to issue interim guidance.